These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6422680)
21. [Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime]. Aleksandrova IA; Moroz AF; Antsiferova NG; Aleksandrov AD Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):72-5. PubMed ID: 3099518 [TBL] [Abstract][Full Text] [Related]
22. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes]. Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445 [TBL] [Abstract][Full Text] [Related]
23. [Pseudomonas aeruginosa slime: chemical composition and biological characteristics]. Moroz AF; Antsiferova NG; Aleksandrov AD Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):6-12. PubMed ID: 6172917 [No Abstract] [Full Text] [Related]
24. [Isolation and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. An evaluation of the biological properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Ttitova TI; Grigor'ev NI; Antsiferova NG; Radkevich SA; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):14-8. PubMed ID: 3931392 [TBL] [Abstract][Full Text] [Related]
25. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa. Gościniak G; Grzybek-Hryncewicz K Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637 [TBL] [Abstract][Full Text] [Related]
26. [Immunologic study of the cellular components of bacillus pyocyaneus. V. Antigenic analysis of slime and its fractions]. Zaĭdner IG; Stanislavskiĭ ES; Kolker II; Grishina IA; Palkina NA Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):41-5. PubMed ID: 91285 [TBL] [Abstract][Full Text] [Related]
27. Immunogenic properties of slime produced by Pseudomonas aeruginosa. Maresz-Babczyszyn J; Sokalska M Arch Immunol Ther Exp (Warsz); 1979; 27(4):585-9. PubMed ID: 117786 [TBL] [Abstract][Full Text] [Related]
28. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165 [TBL] [Abstract][Full Text] [Related]
29. Interaction of the extracellular slime of Pseudomonas aeruginosa with antibody and complement (C). Gancevici G; Toporan M Arch Roum Pathol Exp Microbiol; 1983; 42(1):15-24. PubMed ID: 6443847 [No Abstract] [Full Text] [Related]
30. [Production and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. IV. The effect of immunization with Pseudomonas aeruginosa vaccine on the immune status of volunteer donors]. Titova TI; Sidorova TN; Radkevich SA; Antsiferova NG; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):80-4. PubMed ID: 3933225 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa. Afshari H; Maleki M; Hakimian M; Tanha RA; Salouti M J Immunol Methods; 2021 Jan; 488():112938. PubMed ID: 33259781 [TBL] [Abstract][Full Text] [Related]
32. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey). Joó I; Stanislavskii ES J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316 [TBL] [Abstract][Full Text] [Related]
34. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification. Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473 [TBL] [Abstract][Full Text] [Related]